Trademark: 97471499
Word
ELUDE
Status
Pending
Status Code
730
Status Date
Thursday, January 4, 2024
Serial Number
97471499
Mark Type
4000
Filing Date
Wednesday, June 22, 2022
Published for Opposition
Tuesday, May 9, 2023

Trademark Owner History
GentiBio, Inc. - Owner At Publication

Classifications
40 Custom manufacture of pharmaceuticals for others; Custom manufacturing of biological cells; consultation in the field of custom manufacture of pharmaceuticals and biological cells
5 Gene therapy products, namely, engineered cell platforms for immunotherapy purposes; Pharmaceutical preparations for use in the treatment of autoimmune diseases and disorders, autoinflammatory diseases and disorders, alloimmune diseases and disorders and allergic diseases and disorders
42 Scientific research; Pharmaceutical research; Medical research; Engineering of biological cells; genetic engineering of biological cells; Technological consultation services in the fields of engineering of biological cells; Laboratory research services in the field of immunology and cellular engineering

Trademark Events
Jan 4, 2024
Sou Extension 1 Granted
Jan 4, 2024
Sou Extension 1 Filed
Jan 4, 2024
Sou Teas Extension Received
Jul 4, 2023
Noa E-Mailed - Sou Required From Applicant
May 9, 2023
Official Gazette Publication Confirmation E-Mailed
May 9, 2023
Published For Opposition
Apr 19, 2023
Notification Of Notice Of Publication E-Mailed
Apr 3, 2023
Approved For Pub - Principal Register
Apr 3, 2023
Examiner's Amendment Entered
Apr 3, 2023
Notification Of Examiners Amendment E-Mailed
Apr 3, 2023
Examiners Amendment E-Mailed
Apr 3, 2023
Examiners Amendment -Written
Apr 2, 2023
Assigned To Examiner
Jul 12, 2022
New Application Office Supplied Data Entered
Jun 25, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24